Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1766

1.

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.

March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J.

Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. Erratum in: Arch Gen Psychiatry. 2008 Jan;65(1):101.

PMID:
17909125
2.

The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.

March J, Silva S, Vitiello B; TADS Team..

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1393-403.

PMID:
17135984
3.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

4.

Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).

Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, Hughes J, Feeny N, Weller E, Sweeney M, Reinecke M, Pathak S, Ginsburg G, Emslie G, March J; TADS Team..

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1404-11.

PMID:
17135985
5.

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

Curry J, Rohde P, Simons A, Silva S, Vitiello B, Kratochvil C, Reinecke M, Feeny N, Wells K, Pathak S, Weller E, Rosenberg D, Kennard B, Robins M, Ginsburg G, March J; TADS Team..

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1427-39.

PMID:
17135988
6.

Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).

Vitiello B, Rohde P, Silva S, Wells K, Casat C, Waslick B, Simons A, Reinecke M, Weller E, Kratochvil C, Walkup J, Pathak S, Robins M, March J; TADS Team..

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1419-26.

PMID:
17135987
7.

A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.

Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK.

Arch Pediatr Adolesc Med. 2007 Nov;161(11):1026-34.

PMID:
17984403
8.

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team..

JAMA. 2004 Aug 18;292(7):807-20.

PMID:
15315995
9.

Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods.

Treatment for Adolescents With Depression Study Team..

J Am Acad Child Adolesc Psychiatry. 2003 May;42(5):531-42.

PMID:
12707557
10.

Acute time to response in the Treatment for Adolescents with Depression Study (TADS).

Kratochvil C, Emslie G, Silva S, McNulty S, Walkup J, Curry J, Reinecke M, Vitiello B, Rohde P, Feeny N, Casat C, Pathak S, Weller E, May D, Mayes T, Robins M, March J; TADS Team..

J Am Acad Child Adolesc Psychiatry. 2006 Dec;45(12):1412-8.

PMID:
17135986
11.

Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.

Domino ME, Foster EM, Vitiello B, Kratochvil CJ, Burns BJ, Silva SG, Reinecke MA, March JS.

J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):711-20. doi: 10.1097/CHI.0b013e3181a2b319.

PMID:
19465880
12.

The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.

Treatment for Adolescents With Depression Study (TADS) Team., March J, Silva S, Curry J, Wells K, Fairbank J, Burns B, Domino M, Vitiello B, Severe J, Riedal K, Goldman M, Feeny N, Findling R, Stull S, Baab S, Weller EB, Robbins M, Weller RA, Jessani N, Waslick B, Sweeney M, Dublin R, Walkup J, Ginsburg G, Kastelic E, Koo H, Kratochvil C, May D, LaGrone R, Vaughan B, Albano AM, Hirsch GS, Podniesinki E, Chu A, Reincecke M, Leventhal B, Rogers G, Jacobs R, Pathak S, Wells J, Lavanier SA, Danielyan A, Rohde P, Simons A, Grimm J, Frank S, Emslie G, Kennard B, Hughes C, Mayes TL, Rosenberg D, Benazon N, Butkus M, Bartoi M.

Am J Psychiatry. 2009 Oct;166(10):1141-9. doi: 10.1176/appi.ajp.2009.08111620. Epub 2009 Sep 1.

PMID:
19723787
13.
14.

Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.

Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM.

Arch Gen Psychiatry. 2004 Oct;61(10):1005-13.

PMID:
15466674
15.
16.

Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

Mao PX, Tang YL, Jiang F, Shu L, Gu X, Li M, Qian M, Ma C, Mitchell PB, Cai ZJ.

Depress Anxiety. 2008;25(1):46-54.

PMID:
17149753
17.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
18.

Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS).

Vitiello B, Kratochvil CJ, Silva S, Curry J, Reinecke M, Pathak S, Waslick B, Hughes CW, Prentice ED, May DE, March JS.

J Am Acad Child Adolesc Psychiatry. 2007 Dec;46(12):1642-50.

PMID:
18030086
19.
20.

Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).

Lewis CC, Simons AD, Nguyen LJ, Murakami JL, Reid MW, Silva SG, March JS.

J Am Acad Child Adolesc Psychiatry. 2010 Feb;49(2):132-40.

PMID:
20215935

Supplemental Content

Support Center